Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- MEDP +45.4%, IQV +10.5%, DHI +6.4%, CPAC +4.9%, FOR +4.2%, CALX +3.3%, DGX +3.1%, NOC +3%, ZION +2.9%, VLRS +2.7%, IPG +2.6%, HOPE +2.6%, THC +2.2%, OSCR +1.5%, VMI +1.5%, PHM +1.4%, WTFC +1.1%, RLI +1.1%
Other news:
- REPL +7.7% (FDA has issued a Complete Response Letter regarding the Biologics License Application for RP1 in combination with nivolumab for the treatment of advanced melanoma)
- CSX +4.4% (CP and CSX form new rail routing option called Southeast Mexico Express)
- NFGC +4.2% (assessment for Queensway gold project)
- ECX +4% (files for $255 mln mixed securities shelf offering)
- GILT +3.5% (awarded ~$60 million to provide digital inclusion solutions in Peru)
- BLDP +2.6% (receives order for 6.4 MW to eCap Marine for Samskip vessels)
- PARR +1.9% (establish joint venture for renewable fuels in Hawaii)
- ASH +1.8% (names new CFO)
- ERJ +1.7% (Q2 backlog)
- NA +1.2% (has significantly increased its holdings of BNB to 120,000.00, representing a total value of ~ $90 mln)
- PPBI +1% (COLB and PPBI shareholders approve merger)
Analyst comments:
- PAY +5.6% (upgraded to Outperform from Peer Perform at Wolfe Research)
- CLF +1.2% (upgraded to Overweight from Sector Weight at KeyBanc)
- UBS +1.1% (upgraded to Neutral from Underperform at BofA Securities)